pyrazinamide has been researched along with benzbromarone in 46 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 15 (32.61) | 18.7374 |
1990's | 16 (34.78) | 18.2507 |
2000's | 4 (8.70) | 29.6817 |
2010's | 11 (23.91) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
Avery, GS; Brogden, RN; Heel, RC; Speight, TM | 1 |
Fox, IH; Sinclair, DS | 2 |
Agbedana, EO; Higashino, K; Moriwaki, Y; Suda, M; Takahashi, S; Yamamoto, T | 1 |
Agbedana, OE; Hada, T; Higashino, K; Moriwaki, Y; Suda, M; Takahashi, S; Yamamoto, T | 1 |
Tykarski, A | 1 |
Higashino, K; Moriwaki, Y; Suda, M; Takahashi, S; Yamamoto, T | 1 |
Hada, T; Higashino, K; Moriwaki, Y; Takahashi, S; Yamamoto, T | 4 |
Goto, H; Ito, A; Mikami, T | 1 |
Hasegawa, J; Hisatome, I; Ishiko, R; Kotake, H; Mashiba, H; Nakamoto, S; Ogino, K; Saito, M | 1 |
Hasegawa, J; Hisatome, I; Kotake, H; Mashiba, H; Miyamoto, J; Nakamoto, S; Ogino, K; Saito, M | 1 |
Schoeman, HS; Sommers, DK | 1 |
Hwang, TJ; Ito, M; Kuroda, Y; Miyao, M; Naito, E; Takeda, E; Toshima, K; Watanabe, T; Yokota, I | 1 |
Homma, Y; Kitamura, T; Nishimura, Y | 1 |
Kuroda, M; Takeda, R; Tofuku, Y | 1 |
Levinson, DJ; Sorensen, LB | 2 |
Hiroshige, K; Kuroiwa, A; Takasugi, M; Yuu, K | 1 |
Kawai, S; Osawa, G; Yamada, M | 1 |
Posadzy-Małaczyńska, A; Pupek-Musialik, D; Tykarski, A | 1 |
Fujimoto, Y; Hirata, N; Hisatome, I; Kosaka, H; Kotake, H; Mashiba, H; Sato, R; Shigemasa, C; Tanaka, Y; Yoshida, A | 1 |
Hiroshige, K; Kuroiwa, A; Soejima, M; Takasugi, M; Yuu, K | 1 |
Fujimoto, Y; Hisatome, I; Igawa, O; Kosaka, H; Manabe, I; Ohtahara, A; Ohtahara, K; Sawaguchi, M; Shigemasa, C; Takeda, A; Tanaka, Y; Tsuboi, M; Yoshida, A | 1 |
Higashino, K; Hiroishi, K; Moriwaki, Y; Naito, Y; Nasako, Y; Takahashi, S; Yamakita, J; Yamamoto, T | 1 |
Diezi, J; Guisan, B; Roch-Ramel, F | 1 |
Fujita, K; Hirasaki, S; Koide, N; Ogawa, H; Tsuji, T | 1 |
Hamada, N; Hiroe, K; Hisatome, I; Kato, T; Kinugawa, T; Manabe, I; Ogino, K; Ohtahara, A; Sato, R; Shigemasa, C; Shimoyama, M; Takeda, A; Tanaka, Y; Tsuboi, M; Yamamoto, Y; Yoshida, A | 1 |
Decaux, G; Hannotier, P; Musch, W; Prospert, F; Soupart, A | 1 |
Furuyama, T; Ikarashi, T; Ito, S; Kurihara, I; Miura, R; Saito, T; Sato, H; Sato, M; Soma, J; Suzuki, T; Tsunoda, K | 1 |
Endou, H; Hosoya, T; Hosoyamada, M; Ichida, K; Kimura, H; Takeda, M; Utsunomiya, Y | 1 |
Hosoyamada, M; Ichida, K | 1 |
Hasegawa, Y; Ito, O; Ito, S; Kudo, K; Mitsui, H; Sato, H; Sato, K; Yuda, F | 1 |
Mamada, H; Nakanishi, T; Sato, M; Shirasaka, Y; Tamai, I; Wakayama, T | 1 |
Anzai, N; Nakanishi, T; Ohya, K; Shimada, S; Tamai, I | 1 |
3 review(s) available for pyrazinamide and benzbromarone
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Benzbromarone: a review of its pharmacological properties and therapeutic use in gout and hyperuricaemia.
Topics: Aspirin; Benzbromarone; Benzofurans; Drug Interactions; Fasting; Gout; Humans; Kidney Diseases; Kinetics; Lipid Metabolism; Pyrazinamide; Triglycerides; Uric Acid; Xanthine Oxidase | 1977 |
[Molecular mechanism for urinary excretion of hypoxanthine and xanthine].
Topics: Animals; Benzbromarone; Biological Transport; Humans; Hypoxanthine; Hypoxanthine Phosphoribosyltransferase; Kidney; Membrane Transport Proteins; Probenecid; Pyrazinamide; Uricosuric Agents; Xanthine | 2003 |
1 trial(s) available for pyrazinamide and benzbromarone
Article | Year |
---|---|
Effects of pyrazinamide, probenecid, and benzbromarone on renal excretion of oxypurinol.
Topics: Adult; Benzbromarone; Biological Transport; Humans; Kidney; Male; Oxypurinol; Probenecid; Pyrazinamide | 1991 |
42 other study(ies) available for pyrazinamide and benzbromarone
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
The pharmacology of the hypouricemic effect of benzbromarone.
Topics: Aspirin; Benzbromarone; Benzofurans; Blood Proteins; Drug Interactions; Glomerular Filtration Rate; Kidney Tubules; Protein Binding; Pyrazinamide; Sulfinpyrazone; Uric Acid; Xanthine Oxidase | 1977 |
The pharmacology of hypouricemic effect of benzbromarone.
Topics: Adult; Aspirin; Benzbromarone; Benzofurans; Blood Proteins; Creatinine; Female; Gout; Humans; Male; Middle Aged; Protein Binding; Pyrazinamide; Sulfinpyrazone; Uric Acid; Uricosuric Agents | 1975 |
Two cases in whom pyrazinamide does not inhibit the uricosuric action of benzbromarone.
Topics: Adult; Benzbromarone; Diabetes Mellitus, Type 2; Drug Interactions; Female; Humans; Kidney; Kidney Diseases; Male; Pyrazinamide; Uric Acid | 1992 |
Analysis of uric acid transport in renal tubules using benzbromarone and pyrazinamide.
Topics: Absorption; Adult; Benzbromarone; Humans; Kidney Tubules; Male; Middle Aged; Models, Biological; Pyrazinamide; Uric Acid | 1991 |
[Uric acid and arterial hypertension. II. Evaluation of uric acid transport in the nephrons in primary arterial hypertension].
Topics: Adult; Benzbromarone; Biological Transport; Female; Glomerular Filtration Rate; Humans; Hypertension; Kidney Function Tests; Kidney Glomerulus; Kidney Tubules; Male; Middle Aged; Pyrazinamide; Uric Acid | 1991 |
Analysis of uric acid transport in renal tubules using benzbromarone and pyrazinamide.
Topics: Benzbromarone; Benzofurans; Glomerular Filtration Rate; Humans; Kidney Tubules; Male; Pyrazinamide; Uric Acid | 1990 |
Renal excretions of oxypurinol and oxypurines--effects of pyrazinamide, probenecid and benzbromarone.
Topics: Adult; Benzbromarone; Gout Suppressants; Humans; Kidney; Male; Metabolic Clearance Rate; Oxypurinol; Probenecid; Pyrazinamide; Pyrimidines | 1989 |
Renal excretion of purine bases--effects of probenecid, benzbromarone and pyrazinamide.
Topics: Adult; Benzbromarone; Gout Suppressants; Humans; Kidney; Male; Metabolic Clearance Rate; Probenecid; Purines; Pyrazinamide | 1989 |
[Effect of exercise on urate excretion].
Topics: Adult; Benzbromarone; Depression, Chemical; Exercise; Glomerular Filtration Rate; Humans; Kidney; Male; Probenecid; Pyrazinamide; Uric Acid | 1989 |
Cause of persistent hypouricemia in outpatients.
Topics: Benzbromarone; Female; Hematuria; Humans; Male; Outpatients; Patients; Pyrazinamide; Uric Acid | 1989 |
Renal excretion of purine bases. Effects of probenecid, benzbromarone and pyrazinamide.
Topics: Adult; Benzbromarone; Benzofurans; Biological Transport, Active; Female; Humans; Hypoxanthine; Hypoxanthines; Kidney; Male; Probenecid; Purines; Pyrazinamide; Uric Acid; Xanthine; Xanthines | 1988 |
Renal hypouricemia due to an isolated renal defect of urate transport.
Topics: Adult; Benzbromarone; Humans; Kidney; Kidney Diseases; Male; Pyrazinamide; Uric Acid | 1988 |
Drug interactions with urate excretion in man.
Topics: Adult; Ampicillin; Benzbromarone; Benzofurans; Drug Interactions; Humans; Kidney; Kinetics; Male; Probenecid; Pyrazinamide; Uric Acid | 1987 |
Hereditary renal hypouricemia in children.
Topics: Benzbromarone; Child; Child, Preschool; Creatinine; Humans; Kidney Diseases; Kidney Tubules; Metabolic Clearance Rate; Pyrazinamide; Uric Acid | 1985 |
[A case of familial renal hypouricemia associated with bladder cancer].
Topics: Aged; Benzbromarone; Carcinoma, Transitional Cell; Humans; Male; Probenecid; Pyrazinamide; Renal Tubular Transport, Inborn Errors; Uric Acid; Urinary Bladder Neoplasms | 1984 |
Hypouricemia due to renal urate wasting. Two types of tubular transport defect.
Topics: Adult; Benzbromarone; Biological Transport; Creatinine; Female; Glomerular Filtration Rate; Humans; Kidney Tubules, Proximal; Middle Aged; Pyrazinamide; Uric Acid | 1982 |
Renal handling of uric acid in normal and gouty subject: evidence for a 4-component system.
Topics: Absorption; Benzbromarone; Blood Proteins; Female; Gout; Humans; In Vitro Techniques; Kidney; Kidney Tubules; Male; Models, Biological; Protein Binding; Pyrazinamide; Secretory Rate; Temperature; Uric Acid | 1980 |
Isolated defect in postsecretory reabsorption of uric acid.
Topics: Absorption; Adult; Benzbromarone; Female; Humans; Metabolic Diseases; Pyrazinamide; Uric Acid | 1980 |
Pharmacologic evaluation of the renal handling of uric acid and oxypurines.
Topics: Adult; Benzbromarone; Biological Transport; Humans; Hypoxanthine; Hypoxanthines; Kidney Tubules; Male; Probenecid; Pyrazinamide; Uric Acid; Xanthines | 1994 |
Renal hypouricemia: incomplete combined defect.
Topics: Adult; Benzbromarone; Calcium; Humans; Male; Nephrosis, Lipoid; Probenecid; Pyrazinamide; Uric Acid | 1994 |
[Evaluation of uric acid transport in nephrons of patients with calcium nephrolithiasis and hyperuricosuria].
Topics: Absorption; Adult; Benzbromarone; Calcium; Female; Humans; Kidney Calculi; Male; Middle Aged; Nephrons; Pyrazinamide; Recurrence; Uric Acid | 1993 |
Renal hypouricemia due to enhanced tubular secretion of urate associated with urolithiasis: successful treatment of urolithiasis by alkalization of urine K+, Na(+)-citrate.
Topics: Benzbromarone; Citrates; Creatinine; Female; Humans; Hydrogen-Ion Concentration; Kidney Diseases; Kidney Tubules; Middle Aged; Probenecid; Pyrazinamide; Uric Acid; Urinary Calculi | 1993 |
[A study on uric acid excretion in patients with hypouricemia].
Topics: Acute Kidney Injury; Benzbromarone; Diabetes Complications; Diabetes Mellitus; Female; Humans; Kidney; Kidney Function Tests; Male; Middle Aged; Pyrazinamide; Uric Acid | 1993 |
Renal handling of urate in a patient with familial juvenile gouty nephropathy.
Topics: Adolescent; Benzbromarone; Female; Genes, Dominant; Gout; Gout Suppressants; Humans; Kidney; Kidney Failure, Chronic; Male; Pedigree; Probenecid; Pyrazinamide; Renal Agents; Uric Acid; Uricosuric Agents | 1996 |
Uric acid transport in fanconi syndrome with marked renal hypouricemia: analysis using pyrazinamide and benzbromarone.
Topics: Adolescent; Benzbromarone; Fanconi Syndrome; Humans; Kidney; Male; Pyrazinamide; Time Factors; Uric Acid; Uricosuric Agents | 1996 |
Effects of uricosuric and antiuricosuric agents on urate transport in human brush-border membrane vesicles.
Topics: Aged; Benzbromarone; Biological Transport; Biphenyl Compounds; Carbon Radioisotopes; Diuretics; Ethambutol; Humans; Imidazoles; Kidney Cortex; Kidney Neoplasms; Kinetics; Losartan; Microvilli; Middle Aged; Probenecid; Pyrazinamide; Salicylates; Salicylic Acid; Sulfinpyrazone; Tetrazoles; Ticrynafen; Uric Acid; Uricosuric Agents | 1997 |
Two cases of renal hypouricemia with nephrolithiasis.
Topics: Adult; Benzbromarone; Creatinine; Humans; Kidney Calculi; Kidney Tubules; Male; Middle Aged; Pyrazinamide; Uric Acid; Uricosuric Agents | 1997 |
Hematuria in patients with renal hypouricemia.
Topics: Adult; Aged; Aged, 80 and over; Benzbromarone; Creatinine; Female; Hematuria; Humans; Kidney Diseases; Male; Metabolism, Inborn Errors; Middle Aged; Probenecid; Pyrazinamide; Renal Agents; Uric Acid | 1998 |
Restoration of the uricosuric effect of probenecid after triglycylvasopressine administration in a gouty patient.
Topics: Absorption; Acute Kidney Injury; Adult; Anti-Inflammatory Agents; Benzbromarone; Fludrocortisone; Gout; Humans; Kidney Tubules; Lypressin; Male; Probenecid; Pyrazinamide; Receptors, Vasopressin; Renal Agents; Terlipressin; Uric Acid; Uricosuric Agents | 1998 |
A case of exercise-induced acute renal failure in a patient with enhanced renal hypouricaemia.
Topics: Acute Kidney Injury; Adult; Benzbromarone; Exercise; Humans; Male; Pyrazinamide; Renal Tubular Transport, Inborn Errors; Uric Acid; Uricosuric Agents | 2000 |
Urate transport via human PAH transporter hOAT1 and its gene structure.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Benzbromarone; Biological Transport; Blotting, Western; Carbon Radioisotopes; Cell Line; Cloning, Molecular; Exons; Female; Gene Library; Gout; Humans; Kidney; Kidney Diseases; Organic Anion Transport Protein 1; p-Aminohippuric Acid; Probenecid; Protein Structure, Tertiary; Pyrazinamide; Sodium Salicylate; Uric Acid; Uricosuric Agents | 2003 |
A case of exercise-induced acute renal failure in a patient with idiopathic renal hypouricemia developed during antihypertensive therapy with losartan and trichlormethiazide.
Topics: Acute Kidney Injury; Antihypertensive Agents; Benzbromarone; Blood Cell Count; Creatinine; Diuretics; Drug Therapy, Combination; Exercise; Humans; Hypertension; Kidney; Kidney Function Tests; Losartan; Male; Martial Arts; Middle Aged; Pyrazinamide; Sodium Chloride Symporter Inhibitors; Trichlormethiazide; Uric Acid | 2003 |
Identification and functional characterization of uric acid transporter Urat1 (Slc22a12) in rats.
Topics: Animals; Anion Transport Proteins; Benzbromarone; Biological Transport; Epithelial Cells; Female; Humans; Immunohistochemistry; Kidney; Kinetics; Lactates; Male; Microvilli; Oocytes; Pyrazinamide; Rats; Rats, Sprague-Dawley; Rats, Wistar; Uric Acid; Xenopus laevis | 2011 |
Functional cooperation of URAT1 (SLC22A12) and URATv1 (SLC2A9) in renal reabsorption of urate.
Topics: Animals; Benzbromarone; Cells, Cultured; Dogs; Fluorescent Antibody Technique; Glucose Transport Proteins, Facilitative; Humans; Kidney; Lactic Acid; Madin Darby Canine Kidney Cells; Niacin; Oocytes; Organic Anion Transporters; Organic Cation Transport Proteins; Pyrazinamide; Uric Acid; Uricosuric Agents; Vasodilator Agents; Xenopus laevis | 2013 |